BUSINESS BRIEFING / BIOTECHNOLOGY
- Share via
Times Wire Reports
Biogen Idec Inc. shareholders elected one of billionaire investor Carl Icahn’s nominees and two company-backed nominees to its board, the biotechnology company said.
The election of a fourth director was too close to call, according to the company.
Initial results show that shareholders elected Robert W. Pangia, William D. Young and Alex Denner to the board, the company said. Icahn said Tuesday that two of his nominees, Denner and Richard Mulligan, won board seats.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
